Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.26
-0.66 (-3.15%)
At close: Dec 15, 2025, 4:00 PM EST
20.25
-0.01 (-0.05%)
After-hours: Dec 15, 2025, 7:30 PM EST
Neurogene Market Cap
Neurogene has a market cap or net worth of $313.82 million as of December 15, 2025. Its market cap has decreased by -17.97% in one year.
Market Cap
313.82M
Enterprise Value
58.62M
1-Year Change
-17.97%
Ranking
Category
Stock Price
$20.26
Market Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $313.82M, an increase of 62.07%. That is a compound annual growth rate of 27.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 313.82M | -7.58% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.07B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |